top of page
bokehTILE.png

Future Clinical Trials 
Early Access List

Enhancing innate brain glymphatic clearance presents significant potential as a therapeutic approach for neurodegenerative diseases. Nevertheless, additional research is essential to comprehensively understand its capabilities and to develop safe and effective treatments.

 

At Ciatrix, our mission is to broaden the understanding of potential treatments of neurodegenerative diseases through meticulously designed clinical trials. While Alzheimer's disease remains our primary focus, we have identified several other conditions where the dysfunction of the glymphatic system may play a significant role.

 

If you’re interested in potentially participating or staying informed, sign up below. You can contribute to potentially life-changing medical discoveries.

 

Why Enroll?

✔ Get updates on trial progress and recruitment.

✔ Be among the first to learn about participation opportunities.

✔ Help advance groundbreaking research.

Country
Age of Participant
Please select the disease you or the person you are signing up for has been diagnosed with to help us match them with relevant clinical trials.
Alzheimer’s Disease (AD)
Parkinson’s Disease (PD)
Huntington’s Disease (HD)
Amyotrophic Lateral Sclerosis (ALS)
Multiple Sclerosis (MS)
Chronic Traumatic Encephalopathy (CTE)
Lewy Body Dementia (LBD)
Progressive Supranuclear Palsy (PSP)
Frontotemporal Dementia (FTD)
Vascular Dementia (VaD)
Open Angle Glaucoma (OAG)
bottom of page